Stay updated on Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2 on the ClinicalTrials.gov page.
    Difference
    0.0%
    Check dated 2025-11-25T14:45:10.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The page removed a government funding and operating status notice. This is a housekeeping update and does not affect the study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-18T07:30:29.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The screenshots show only minor cosmetic/UI adjustments (layout spacing, fonts, and collapsed sections) with no changes to core study content, eligibility criteria, locations, timelines, or endpoints. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-10-27T21:11:56.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    The page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.
    Difference
    4%
    Check dated 2025-10-05T10:28:14.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T03:22:59.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Updated page revision from v3.0.1 to v3.0.2; removed the Back to Top link.
    Difference
    0.2%
    Check dated 2025-09-13T17:38:30.000Z thumbnail image

Stay in the know with updates to Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial page.